Weltcare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -31.93%
(FY 2020)
- Profit -78.57%
(FY 2020)
- Ebitda 104.01%
(FY 2020)
- Net Worth 844.86%
(FY 2020)
- Total Assets -0.83%
(FY 2020)
About Weltcare Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shankar Manjare and Jyoti Manjare serve as directors at the Company.
- CIN/LLPIN
U24233PN2014PTC150710
- Company No.
150710
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Weltcare Lifesciences Private Limited offer?
Weltcare Lifesciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Minerals and Ores, Industrial Minerals, Surgical Instruments, Agro Farming Services, Agriculture Production Services, Pharmaceutical Medicine.
Who are the key members and board of directors at Weltcare Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar Manjare  | Director | 21-Feb-2014 | Current |
| Jyoti Manjare | Director | 28-Sep-2019 | Current |
Financial Performance of Weltcare Lifesciences.
Weltcare Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 31.93% decrease. The company also saw a substantial fall in profitability, with a 78.57% decrease in profit. The company's net worth Soared by an impressive increase of 844.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Weltcare Lifesciences?
In 2018, Weltcare Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Manjare Patil Logistics Private LimitedActive 6 years 10 monthsShankar Manjare and Jyoti Manjare are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Weltcare Lifesciences?
Unlock and access historical data on people associated with Weltcare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weltcare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weltcare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
